Evidence map›Paper›PMID 15805464›Full record

ArticleGenes & development2005

An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature.

Kaisa Lehti, Edward Allen, Henning Birkedal-Hansen, Kenn Holmbeck, Yasuhiro Miyake, Tae-Hwa Chun, Stephen J Weiss

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Genes & development, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 119 citations in OpenAlex.

  1. Matrix Metalloproteinase 14 in Corneal Neovascularization.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. NLRP3 Is Involved in the Maintenance of Cerebral Pericytes.Frontiers in cellular neuroscience · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis.International journal of clinical and experimental pathology · 2015
    Article
  20. Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.Cellular and molecular life sciences : CMLS · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Kaisa LehtiDivision of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
Edward Allen
Henning Birkedal-Hansen
Kenn Holmbeck
Yasuhiro Miyake
Tae-Hwa Chun
Stephen J Weiss
National Institute of Dental and Craniofacial Research · USNational Institutes of Health · USDiabetes Australia · AUUniversity of Michigan–Ann Arbor · US

Funding

Matrix Metalloproteinases: Remodeling of the Extracellular MatrixZIADE000676 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI ROBEY, PAMELA G · 2009 to 2017
$9.7M
FUNCTION OF THE MEMBRANE TYPE MATRIX METALLOPROTEINASER01CA071699 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEISS, STEPHEN J · 1997 to 2024
$7.3M
Matrix Metalloproteinases: Remodelling of the ExtracelluZ01DE000676 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI ROBEY, PAMELA G · 1996 to 2008
$2.3M
NCI NIH HHS R01 CA071699NCI NIH HHS R01 CA71699
6 · The paper itself

Abstract

Platelet-derived growth factor (PDGF)/PDGFRbeta-dependent investment of the vascular endothelium by mural cells (i.e., pericytes and vascular smooth muscle cells; VSMCs) is critical for normal vessel wall structure and function. In the developing vasculature, mural cell recruitment is associated with the functionally undefined expression of the type I transmembrane proteinase, membrane-type 1 matrix metalloproteinase (MT1-MMP). In this paper, using VSMCs and tissues isolated from gene-targeted mice, we identify MT1-MMP as a PDGF-B-selective regulator of PDGFRbeta-dependent signal transduction and mural cell function. In VSMCs, catalytically active MT1-MMP associates with PDGFRbeta in membrane complexes that support the efficient induction of mitogenic signaling by PDGF-B in a matrix metalloproteinase inhibitor-sensitive fashion. In contrast, MT1-MMP-deficient VSMCs display PDGF-B-selective defects in chemotaxis and proliferation as well as ERK1/2 and Akt activation that can be rescued in tandem fashion following retroviral transduction with the wild-type protease. Consistent with these in vitro findings, MT1-MMP-deficient brain tissues display a marked reduction in mural cell density as well as abnormal vessel wall morphology similar to that reported in mice expressing PDGF-B or PDGFRbeta hypomorphic alleles. Together, these data identify MT1-MMP as a novel proteolytic modifier of PDGF-B/PDGFRbeta signal transduction that cooperatively regulates vessel wall architecture in vivo.

Indexed as

AnimalsBrainBromodeoxyuridineChemotaxisEndothelium, VascularFluorescent Antibody TechniqueImmunoblottingImmunoprecipitationIn Situ Nick-End LabelingMatrix MetalloproteinasesMiceMitogen-Activated Protein Kinase 3Muscle, Smooth, VascularMyocytes, Smooth MuscleProtein Serine-Threonine KinasesProto-Oncogene ProteinsBromodeoxyuridineMatrix MetalloproteinasesMitogen-Activated Protein Kinase 3Protein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktReceptor, Platelet-Derived Growth Factor beta

Identifiers

PMID15805464
PMCPMC1080136
OpenAlexW2140563259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.